AI-generated from publicly available materials.Netcompany has secured a substantial five-year contract with NHS England, valued at over £215 million, to enhance the digital framework for adult screening programs across the UK.
This contract encompasses all seven national adult screening initiatives, including those for breast, cervical, and bowel cancers, which collectively generate approximately 15 million invitations annually and are critical for saving lives. The digital infrastructure will be integral to the NHS Digital Prevention Services Programme (DPSP), aligning with the NHS's goal to prioritize preventative care as highlighted in its 10 Year Plan.
Netcompany aims to facilitate earlier diagnoses and quicker treatments by improving existing digital services and developing new ones. This includes a revamped national breast screening service and an upgraded cervical screening program that will utilize digital invitations and provide at-home HPV self-testing kits. The focus is on increasing early disease detection, reducing the turnaround time for results, and simplifying participation in screening programs.
Importantly, Netcompany emphasizes that the new services will be UK-built and NHS-controlled, with a commitment to engaging local partners, directing a third of contract revenues towards small and medium-sized enterprises. Amidst ongoing discussions regarding the digital transformation of the NHS, particularly concerning the role of US tech firm Palantir, Netcompany's established history with the NHS—having previously implemented a national online GP registration service—positions it as a trusted partner in this ambitious initiative. This contract underscores the critical importance of modernizing screening processes to enhance public health outcomes.